Shanghai-Shenzhen Stock Connect ETFs Daily Report: Innovative drug ETFs surge over 7%! Fintech and software broadly pull back, pharma and growth stage a full comeback - 20260807
NewTimeSpace News: On 7 August 2026, the Shanghai-Shenzhen Stock Connect ETFs market saw innovative drugs, biomedicine and STAR growth directions surge across the board, while fintech, software, banks and dividend sectors pulled back modestly, with the pharmaceutical sector becoming the absolute main theme of the day.
Innovative drug and biomedicine themes performed extremely strongly, with multiple related ETFs rising more than 5.5%. E Fund CSI Innovative Drugs ETF (516080.SH) rose 7.06%, leading the gains; Yinhua CSI Innovative Drugs Industry ETF (159992.SZ) rose 6.56%; GF CSI Innovative Drugs Industry ETF (515120.SH) rose 6.42%; Tianhong CNI BIOMEDICINE ETF (159859.SZ) rose 5.93%; E Fund SSE Science And Technology Innovation Board Growth ETF (588020.SH) rose 5.93%; Guotai CSI BIOMEDICINE ETF (512290.SH) rose 5.92%; China Universal CNI BIOMEDICINE ETF (159839.SZ) rose 5.82%; and E Fund CSI Biotechnology Thematic ETF (159837.SZ) rose 5.54%.
The STAR 200 direction also strengthened: E Fund China Science And Technology Innovation Board 200 ETF (588270.SH) rose 5.16% and Huatai-PB China Science And Technology Innovation Board 200 ETF (588230.SH) rose 4.90%. Overall, the innovative drug, biomedicine and STAR growth directions formed a strong sector linkage effect, with all top ten gainers rising more than 4.9% and the pharmaceutical sector breaking out across the board.
Shanghai-Shenzhen Stock Connect ETF Top 10 Gainers |
|||||
|
Rank |
Code |
Name |
Change (%) |
Tracking Index |
Manager |
|
1 |
516080.SH |
E Fund CSI Innovative Drugs ETF |
7.06 |
CSI Innovative Drugs Industry Index |
E Fund Management |
|
2 |
159992.SZ |
Yinhua CSI Innovative Drugs Industry ETF |
6.56 |
CSI Innovative Drugs Industry Index |
Yinhua Fund Management |
|
3 |
515120.SH |
GF CSI Innovative Drugs Industry ETF |
6.42 |
CSI Innovative Drugs Industry Index |
GF Fund Management |
|
4 |
159859.SZ |
Tianhong CNI BIOMEDICINE ETF |
5.93 |
CNI Biomedicine Index |
Tianhong Asset Management |
|
5 |
588020.SH |
E Fund SSE Science And Technology Innovation Board Growth ETF |
5.93 |
SSE STAR Growth Index |
E Fund Management |
|
6 |
512290.SH |
Guotai CSI BIOMEDICINE ETF |
5.92 |
CSI BIOMEDICINE Index |
Guotai Asset Management |
|
7 |
159839.SZ |
China Universal CNI BIOMEDICINE ETF |
5.82 |
CNI Biomedicine Index |
China Universal Asset Management |
|
8 |
159837.SZ |
E Fund CSI Biotechnology Thematic ETF |
5.54 |
CSI Biotechnology Thematic Index |
E Fund Management |
|
9 |
588270.SH |
E Fund China Science And Technology Innovation Board 200 ETF |
5.16 |
SSE STAR 200 Index |
E Fund Management |
|
10 |
588230.SH |
Huatai-PB China Science And Technology Innovation Board 200 ETF |
4.90 |
SSE STAR 200 Index |
Huatai-PineBridge Fund Management |
|
Source/Compiled by: Wind / NewTimeSpace Research Institute, as of the close onAugust 7, 2026 |
|||||
On the downside, fintech and software sectors led the declines, though the magnitude was limited overall. ChinaAMC CSI Financials Theme ETF (516100.SH) fell 1.83%, the largest drop; Bosera CSI Financials Theme ETF (516860.SH) fell 1.52%; Guotai CSI All Share Software ETF (515230.SH) fell 1.34%; Hwabao WP CSI Financials Theme ETF (159851.SZ) fell 1.23%; and Harvest CSI Software Services ETF (159852.SZ) fell 1.08%.
Multiple bank products pulled back modestly: E Fund CSI Banks ETF (516310.SH) fell 0.90%; Hwabao WP CSI Banks ETF (512800.SH) fell 0.87%; ChinaAMC CSI Banks ETF (515020.SH) fell 0.87%; Fullgoal CSI 800 Banks ETF (159887.SZ) fell 0.84%; and Hwabao WP S&P China A-Share Dividend Opportunities ETF (562060.SH) fell 0.81%. Fintech, software, banks and dividend products came under pressure on the day, but none fell more than 1.9%.
Shanghai-Shenzhen Stock Connect ETF Top 10 Losers |
|||||
|
Rank |
Code |
Name |
Change (%) |
Tracking Index |
Manager |
|
1 |
516100.SH |
ChinaAMC CSI Financials Theme ETF |
-1.83 |
CSI Financial Technology Theme Index |
China Asset Management |
|
2 |
516860.SH |
Bosera CSI Financials Theme ETF |
-1.52 |
CSI Financial Technology Theme Index |
Bosera Asset Management |
|
3 |
515230.SH |
Guotai CSI All Share Software ETF |
-1.34 |
CSI All Share Software Index |
Guotai Asset Management |
|
4 |
159851.SZ |
Hwabao WP CSI Financials Theme ETF |
-1.23 |
CSI Financial Technology Theme Index |
Hwabao WP Fund Management |
|
5 |
159852.SZ |
Harvest CSI Software Services ETF |
-1.08 |
CSI Software Services Index |
Harvest Fund Management |
|
6 |
516310.SH |
E Fund CSI Banks ETF |
-0.90 |
CSI Banks Index |
E Fund Management |
|
7 |
512800.SH |
Hwabao WP CSI Banks ETF |
-0.87 |
CSI Banks Index |
Hwabao WP Fund Management |
|
8 |
515020.SH |
ChinaAMC CSI Banks ETF |
-0.87 |
CSI Banks Index |
China Asset Management |
|
9 |
159887.SZ |
Fullgoal CSI 800 Banks ETF |
-0.84 |
CSI 800 Banks Index |
Fullgoal Fund Management |
|
10 |
562060.SH |
Hwabao WP S&P China A-Share Dividend Opportunities ETF |
-0.81 |
S&P China A-Share Dividend Opportunities Index |
Hwabao WP Fund Management |
|
Source/Compiled by: Wind / NewTimeSpace Research Institute, as of the close onAugust 7, 2026 |
|||||
Data from NewTimeSpace Research showed that on 7 August 2026 the Shanghai-Shenzhen Stock Connect ETFs market exhibited a rotation pattern of the pharmaceutical sector breaking out across the board while fintech and bank sectors came under pressure. The innovative drug, biomedicine and STAR growth directions attracted concentrated buying and led the gains, with the pharmaceutical sector becoming the absolute main theme of the day, while fintech, software, banks and dividend sectors pulled back modestly. Market hotspots rotated rapidly from the previous day's coal and semiconductors to innovative drugs and biomedicine, with the pharmaceutical sector staging a full comeback after sustained prior adjustments, and the pace of sector rotation remaining relatively fast.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
